Agree 100%
Anthropic CEO Dario Amodei thinks cancer, Alzheimer’s, heart disease, and mental illness will be “relics of the past” in less than a decade, thanks to AI.View quoted post on X
andrewdudum
Verified account This account is verified. Learn more@AndrewDudum
Founder & CEO $HIMS.
6 Following 62K Followers 3.4K Posts
Latest posts 5
Our Q3 2026 results are now live!
We believe that in healthcare, whoever owns the customer relationship wins. We’re building an everyday digital health platform that millions of people can rely on, not just for a single treatment, but for the whole experience of getting and staying well. We’re making substantial progress: revenue growth accelerated to nearly 50% this quarter. Nearly three million people across four continents rely on us to access care.
Here’s how we’re continuing to push forward:
- Winning metabolic health. For many people, the relationship with Hims & Hers starts with weight loss, and we’re making care easier to access: one seamless experience across an assortment of weight loss medicines, including from @novonordisk and @EliLillyandCo, more flexible multi-month subscriptions that we’re preparing ahead of the new year, and an AI-native experience that now reaches the large majority of weight loss customers.
- Winning the major global markets: International revenue grew more than 4x year-over-year to $233 million, and is on track to reach a $1 billion annual run rate in 2027. Our reach now spans four continents, and we’re introducing the Hims & Hers brands to new markets, including Australia and Germany.
- Staying at the forefront of category expansion: Our platform helps us go deeper into complex care and launch specialties faster. For example, we launched controlled substances for the first time with injectable and oral TRT, and we’re excited to be launching our Peptides+ offering later this month.
We also announced today that @hubermanlab is joining our Board of Directors, and he’s also joining us as an advisor. I’ve spent a lot of time with Andrew over the past year and we’re in lock step on what matters: making the latest health innovations accessible and actionable for people everywhere.
This is how we’re building the platform that will redefine how people access healthcare. I can’t wait for you to see what comes next.
More on this quarter’s results, including important disclaimers: news.hims.com/newsroom/how-w…
We believe that in healthcare, whoever owns the customer relationship wins. We’re building an everyday digital health platform that millions of people can rely on, not just for a single treatment, but for the whole experience of getting and staying well. We’re making substantial progress: revenue growth accelerated to nearly 50% this quarter. Nearly three million people across four continents rely on us to access care.
Here’s how we’re continuing to push forward:
- Winning metabolic health. For many people, the relationship with Hims & Hers starts with weight loss, and we’re making care easier to access: one seamless experience across an assortment of weight loss medicines, including from @novonordisk and @EliLillyandCo, more flexible multi-month subscriptions that we’re preparing ahead of the new year, and an AI-native experience that now reaches the large majority of weight loss customers.
- Winning the major global markets: International revenue grew more than 4x year-over-year to $233 million, and is on track to reach a $1 billion annual run rate in 2027. Our reach now spans four continents, and we’re introducing the Hims & Hers brands to new markets, including Australia and Germany.
- Staying at the forefront of category expansion: Our platform helps us go deeper into complex care and launch specialties faster. For example, we launched controlled substances for the first time with injectable and oral TRT, and we’re excited to be launching our Peptides+ offering later this month.
We also announced today that @hubermanlab is joining our Board of Directors, and he’s also joining us as an advisor. I’ve spent a lot of time with Andrew over the past year and we’re in lock step on what matters: making the latest health innovations accessible and actionable for people everywhere.
This is how we’re building the platform that will redefine how people access healthcare. I can’t wait for you to see what comes next.
More on this quarter’s results, including important disclaimers: news.hims.com/newsroom/how-w…
news.hims.com How We’re Building the Customer Relationship in Health Health is shifting from one-off transactions to lifelong relationships. We’re building the platform to earn them in every category and every market. I look forward to this part of the earnings cycle every quarter – hearing directly from the Hims & Hers community. Send your questions to investors@forhims.com this weekend, and we’ll answer the most popular live on Monday afternoon.
People deserve to have access to the most innovative treatments. That’s why we work with leaders across the industry, and starting today, that includes @EliLillyandCo.
When innovators work together, it’s better for everyone. Customers can access more personal care, providers have a well-rounded picture of how their patients are doing, and drugmakers can be confident that the people who need their medications the most will be able to get their hands on it and stick to it.
Lilly is one of the most innovative companies in the world, and we share a commitment to reaching real people with real impact. Working together means we can combine some of the world’s best medicines with our powerful platform to help more people feel great.
Read more, including important info: news.hims.com/newsroom/lilly…
When innovators work together, it’s better for everyone. Customers can access more personal care, providers have a well-rounded picture of how their patients are doing, and drugmakers can be confident that the people who need their medications the most will be able to get their hands on it and stick to it.
Lilly is one of the most innovative companies in the world, and we share a commitment to reaching real people with real impact. Working together means we can combine some of the world’s best medicines with our powerful platform to help more people feel great.
Read more, including important info: news.hims.com/newsroom/lilly…
news.hims.com Lilly and Hims & Hers Expand Access to FDA-Approved Lilly Medicines The agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform beautiful and powerful work airing on NFL this week!
youtube.com/watch?v=o81RYM…
youtube.com/watch?v=o81RYM…
www.youtube.com “I’m him” | Official TV Commercial | Hims Your best self isn’t given. It’s built. One choice, one move, one m...